{"name":"Adenovir Pharma","permalink":"adenovir-pharma","crunchbase_url":"http://www.crunchbase.com/company/adenovir-pharma","homepage_url":"http://www.adenovir.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@adenovir.com","phone_number":"+46-(0)42-38 74 28","description":"","created_at":"Wed Jul 07 02:24:24 UTC 2010","updated_at":"Wed Jul 07 02:24:22 UTC 2010","overview":"<p>Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.</p>\n\n<p>Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma is located in Helsingborg Sweden in one of Europeâ€™s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.</p>\n\n<p>With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).</p>","image":null,"products":[],"relationships":[{"is_past":false,"title":"Chairman","person":{"first_name":"Stefan","last_name":"Appelgren","permalink":"stefan-appelgren","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$787k","funding_rounds":[{"round_code":"unattributed","source_url":"","source_description":"Cap funding Report","raised_amount":787000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":15,"investments":[{"company":null,"financial_org":{"name":"SÃ¤tila Holding","permalink":"stila-holding-ab","image":null},"person":null},{"company":null,"financial_org":{"name":"Sparbankstiftelsen SkÃ¥nes Riskkapitalstiftels","permalink":"sparbankstiftelsen-sknes-riskkapitalstiftels","image":null},"person":null},{"company":null,"financial_org":{"name":"LÃ¤nsfÃ¶rsÃ¤kringar SkÃ¥ne","permalink":"lnsfrskringar-skne","image":null},"person":null},{"company":null,"financial_org":{"name":"Augmenta","permalink":"augmenta","image":{"available_sizes":[[[150,26],"assets/images/resized/0010/0265/100265v1-max-150x150.jpg"],[[250,44],"assets/images/resized/0010/0265/100265v1-max-250x250.jpg"],[[296,53],"assets/images/resized/0010/0265/100265v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"P.U.L.S.","permalink":"p-u-l-s","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Kullagatan 8","address2":"","zip_code":"SE-252 20","city":"Helsingborg","state_code":null,"country_code":"SWE","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}